Overview

A Study To Investigate Safety, Tolerability, And Pharmacokinetics Of PF-00868554 In Japanese Healthy Adult Volunteers

Status:
Terminated
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
Investigation of safety, tolerability, and pharmacokinetics of PF-00868554 following multiple oral administrations of PF-00868554 in Japanese healthy adult volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer